Company intelligence / Profile preview

CB2 Insights

Mississauga, Ontario, Canadaglobenewswire.com ↗

Ownership: Private
Development stage: Commercial

Overview

CB2 Insights operates a network of medical cannabis evaluation and education centers across multiple US states, treating over 100,000 patients annually. The company has developed technology solutions for clinical data management and electronic data capture to support medical cannabis research and treatment.

Therapeutic areas: OtherPsychiatryNeurology
Modalities: Medical Cannabis
Industry: Non-Academic Healthcare

Partnerships

FCM Global

Beyond the preview

Go deeper on CB2 Insights.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CB2 Insights.

Explore the full profile